From the Journals

High testosterone in postmenopausal women may add CVD risk

View on the News

New perspective on sex steroids and CV risk

This study offers new insights into the relationships between endogenous hormones and how they influence cardiovascular event risk, according to Virginia M. Miller, PhD, and Rekha Mankad, MD.

Previous observational studies have established that decreases in endogenous estrogen led to increases in cardiovascular event risk and incidence, Dr. Miller and Dr. Mankad said in an editorial referencing the study.

What’s less clear is the role of testosterone in cardiovascular risk and event incidence, both by itself and in relation to other endogenous hormones.

“Few studies have gone beyond singular associations of hormone levels with cardiovascular events,” the editorial authors wrote in the Journal of the American College of Cardiology.

The study by Zhao and her colleagues is unique in part because their analysis considers the ratio of testosterone to estradiol. In particular, they found that a higher testosterone to estradiol level was associated with a higher incidence of cardiovascular events overall and of coronary heart disease.

What was unexpected, according to Dr. Miller and Dr. Mankad, was a U-shaped association with incident heart failure. In subgroup analysis, investigators found a positive association between testosterone to estradiol ratio and heart failure with reduced ejection fraction but not with heart failure with preserved ejection fraction.

“By addressing a set of defined incident events, this study provides new information needed to develop mechanistic hypotheses of causal relationships of hormones with specific aspects of cardiac function,” the editorial authors wrote.

Dr. Miller and Dr. Mankad are both with the women’s health research center and department of cardiovascular disease at the Women’s Heart Clinic at the Mayo Clinic, Rochester, Minn. These comments are derived from their editorial in the Journal of the American College of Cardiology. Dr. Mankad had no disclosures, while Dr. Miller reported support from a National Institutes of Health grant.


 

FROM THE JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY


Investigators also reported a statistically significant association between total testosterone levels and risk of cardiovascular disease and coronary heart disease but not risk of heart failure.

In a subgroup analysis of postmenopausal women with heart failure, investigators found a significant positive association with the testosterone to estradiol ratio (HR, 1.65; 95% CI, 1.07-2.54) and inverse associations for estradiol (HR, 0.60; 95% CI, 0.39-0.93) and for dehydroepiandrosterone (HR, 0.59; 95% CI, 0.44-0.78).

On their own, estradiol levels had no association with cardiovascular disease events overall, but they were associated with lower coronary heart disease risk, according to investigators. Estradiol also was associated with a lower heart failure risk, though the trend did not reach statistical significance.

The study was partially funded by the American Heart Association’s Go Red for Women Research Network. Study authors reported disclosures related to Cordex Systems, Siemens Diagnostics, and other entities.

SOURCE: Zhao D et al. J Am Coll Cardiol. 2018 Jun 5; 71:2555-66.

Pages

Recommended Reading

FDA panels revisit rosiglitazone's cardiovascular safety
Clinician Reviews
VIDEO: End of the road for aspirin in primary prevention?
Clinician Reviews
$30 million NIA Consortium Explores Links Between Vascular Health and Alzheimer Disease
Clinician Reviews
CABG best for diabetes patients with CKD – or is it?
Clinician Reviews
VIDEO: New antisense inhibitor nets impressive reductions in lipids
Clinician Reviews
When to screen asymptomatic diabetics for CAD
Clinician Reviews
HT use associated with lower postmenopausal coronary artery calcium scores
Clinician Reviews
Providers buck lipid recommendations in high-risk diabetes
Clinician Reviews
Higher BP targets suggested for elderly, cognitively impaired
Clinician Reviews
Atopic eczema linked to cardiovascular disease risk
Clinician Reviews